Recently, Maciej et al. showed that SF3A3 selectively regulates MYC-driven splicing and metabolic reprogramming, and the expression level of SF3A3 affects MYC-induced oncogenesis and breast cancer plasticity. The gene discussed is MYC; the disease is breast carcinoma.